S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Repligen Corp

RGEN XNAS
$123.46 -2.97 (-2.35%) ▼ 15-min delayed
Open
$125.83
High
$126.83
Low
$121.26
Volume
995.2K
Market Cap
$6.96B

About Repligen Corp

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 2.0K Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $194.25M $8.33M $0.15
FY 2025 $738.26M $48.89M $0.87
Q3 2025 $188.81M $14.91M $0.27
Q2 2025 $182.37M $14.87M $0.26

Related Market News

No specific coverage for RGEN yet. Check out our latest market news or earnings calendar.

Get RGEN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Repligen Corp.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.